Bidirectional associations between rheumatoid arthritis and depression: A nationwide longitudinal study

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lu, Ming Chi ^a,b   Guo, How Ran ^c,d   Lin, Miao Chiu ^a   Livneh, Hanoch ^e   Lai, Ning Sheng ^a,b   Tsai, Tzung Yi ^a,c,f  

^a DALIN TZU CHI HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e PORTLAND STATE UNIVERSITY   (United States)

^f TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTHRITIS, RHEUMATOID; CLINICAL TRIAL; COMPLICATION; DEPRESSION; FACTUAL DATABASE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; TAIWAN; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DATABASES, FACTUAL; DEPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TAIWAN;

EID: 84957539717     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20647     Document Type: Article

References (30)

1. Rathbun, A. M., Reed, G. W. & Harrold, L. R. The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: a systematic review. Rheumatology 52, 1785-1794, doi: 10.1093/rheumatology/kes356 (2013).
2. Irwin, M. R., Davis, M. & Zautra, A. Behavioral comorbidities in rheumatoid arthritis: a psychoneuroimmunological perspective. Psychiatr. Times 25, 1 (2008).
3. Matcham, F., Rayner, L., Steer, S. & Hotopf, M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 52, 2136-2148, doi: 10.1093/rheumatology/ket169 (2013).
4. Wolfe, F. & Michaud, K. Predicting depression in rheumatoid arthritis: The signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum. 61, 667-673, doi:10.1002/art.24428 (2009).
5. Margaretten, M. et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res. 63, 240-246, doi:10.1002/acr.20345 (2011).
6. Joyce, A. T., Smith, P., Khandker, R., Melin, J. M. & Singh, A. Hidden cost of rheumatoid arthritis (RA): Estimating cost of comorbid cardiovascular disease and depression among patients with RA. J. Rheumatol. 36, 743-752, doi:10.3899/jrheum.080670 (2009).
7. Ang, D. C., Choi, H., Kroenke, K. & Wolfe, F. Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J. Rheumatol. 32, 1013-1019 (2005).
8. Kemeny, M. E. & Schedlowski, M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav. Immun. 21, 1009-1018, doi: 〈http://dx.doi.org/10.1016/j.bbi.2007.07.010>(2007).
9. Straub, R. H., Dhabhar, F. S., Bijlsma, J. W. J. & Cutolo, M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum. 52, 16-26, doi:10.1002/art.20747 (2005).
10. Malemud, C. J. Intracellular signaling pathways in rheumatoid arthritis. J. Clin. Cell. Immunol. 4, 160 (2013).
11. Malemud, C. J. & Miller, A. H. Pro-inflammatory cytokine-induced SAPK/MAPK and JAK/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin. Ther. Targets 12, 171-183, doi:10.1517/14728222.12.2.171 (2008).
12. Tost, H., Alam, T. & Meyer-Lindenberg, A. Dopamine and psychosis: Theory, pathomechanisms and intermediate phenotypes. Neurosci. Biobehav. Rev. 34, 689-700, doi: 〈http://dx.doi.org/10.1016/j.neubiorev.2009.06.005〉 (2010).
13. Lin, M. C. et al. Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study. Clinics 70, 91-96 (2015).
14. van 't Land, H. et al. The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. J. Psychosom. Res. 68, 187-193 (2010).
15. Patten, S. B. et al. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen. Hosp. Psychiatry 30, 407-413 (2008).
16. Farmer, A. et al. Medical disorders in people with recurrent depression. Br. J. Psychiatry 192, 351-355, doi:10.1192/bjp. bp.107.038380 (2008).
17. Birnbaum, H. et al. Societal cost of rheumatoid arthritis patients in the US. Curr. Med. Res. Opin. 26, 77-90, doi:10.1185/03007990903422307 (2010).
18. Coty, M. B. & Wishnia, G. Adjusting to recent onset of rheumatoid arthritis: a qualitative study. J. Res. Nurs. 18, 504-517, doi:10.1177/1744987112451263 (2012).
19. Margaretten, M., Julian, L., Katz, P. & Yelin, E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int. J. Clin. Rheumatol. 6, 617-623 (2011).
20. Cutolo, M. & Straub, R. H. Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation 13, 277-282 (2006).
21. Tillmann, T., Krishnadas, R., Cavanagh, J. & Petrides, K. Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: an exploratory case-control study. Arthritis Res.Ther. 15, R45 (2013).
22. Bijl, R. V., de Graaf, R., Ravelli, A., Smit, F. & Vollebergh, W. A. M. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population. Soc. Psychiatry Psychiatr. Epidemiol. 37, 372-379, doi:10.1007/s00127-002-0566-3 (2002).
23. Li, F. et al. Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese han population: a casecontrol study and a meta-analysis. Sci. Rep. 4 (2014).
24. Turnbull, A. V. & Rivier, C. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 9, 253-275, doi: 〈http://dx.doi.org/10.1006/brbi.1995.1026〉 (1995).
25. Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446-457, doi:10.1016/j.biopsych.2009.09.033 (2010).
26. Itoh, T. et al. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J. Immunol. 169, 2643-2647, doi:10.4049/jimmunol.169.5.2643 (2002).
27. Duman, R. S. & Voleti, B. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci. 35, 47-56, doi: 〈http://dx.doi.org/10.1016/j.tins.2011.11.004〉 (2012).
28. Duric, V. et al. Negative regulator of MAP kinase is increased in depression and is necessary and sufficient for expression of depressive behavior. Nat. Med. 16, 1328-1332 (2010).
29. National Health Insurance Research Database (2011). LHID 2000. Available at: Retrieved from 〈http://nhird.nhri.org.tw/date-cohort.htm#3〉. Accessed May 8, 2014.
30. Liu, C. Y. et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J. Health Manage. 4, 1-22 (2006).